Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Key Senior Management Appointments

1 Jun 2015 13:34

RNS Number : 8176O
Plant Impact PLC
01 June 2015
 

For Immediate Release

1 June 2015

 

Plant Impact plc

("Plant Impact" or "the Company")

 

Key Senior Management Appointments

 

Plant Impact plc (AIM: PIM), an agricultural bioscience company that develops and markets crop enhancement and specialty nutrition products, is pleased to announce two senior management appointments to drive the Company's international growth. The appointment of Daryl Thomas and John McGillivray will be effective from 1 June 2015.

 

Daryl Thomas joins Plant Impact as Senior Director, Global Marketing and Business Development. He has substantial commercial and industry experience following 20 years at Syngenta where he held a number of senior business unit and commercial leadership roles. From 2001 he led Syngenta's Integration and long-term planning programs following the merger between the Agribusiness divisions of Zeneca and Novartis. He subsequently was appointed to lead the Global Materials Protection and Home Care business units before assuming leadership for Syngenta's Sugarbeet Seeds business (Hilleshog) for four years, generating sales of more than $200m and with overall responsibility for more than 200 staff. Prior to joining Plant Impact, his most recent position at Syngenta was as Global Head of Commercial Excellence, where he oversaw Syngenta's commercial leverage programs in pricing, marketing, selling and forecasting across Syngenta's Regional and Country business units. His proven expertise in growing market share and leading strategic marketing activities will be a valuable addition to the Plant Impact management team.

 

John McGillivray is appointed as Commercial Director, Europe Middle East Africa. He has 30 years of commercial experience of managing businesses, teams and distribution relationships across the agrochemical, farming and biofuel industries. His previous roles include Business Manager at Wilmar Bioethanol, and various Country Managing Director roles at Syngenta and its predecessor companies. John's extensive commercial leadership experience in markets as diverse as Africa, Middle East, Asia and Australia puts him in a strong position to manage the disparate market practices across the Company's EMEA business. Having managed successful businesses and product portfolios ranging from $30m - $350m in annual turnover, John understands the commercial opportunities and challenges of a growing organisation like Plant Impact.

 

John Brubaker, CEO of Plant Impact, commented:

 

"We are delighted to have appointed Daryl and John to lead our Global Marketing and EMEA Commercial teams. They bring a wealth of worldwide experience and knowledge of our industry that will both strengthen our management team and enable the expansion of our technology into broad acre crops such as soy and wheat".

 

 

For further information, contact:

Plant Impact

John Brubaker, Chief Executive Tel: +44(0) 1582 465 540

www.plantimpact.com

 

Peel Hunt - Nominated Advisor and Broker

Dan Webster Tel: +44 (0) 207 418 8900

Richard Brown

George Sellar

 

Buchanan

 

Charles Ryland Tel: +44(0) 20 7466 5000

Sophie Cowles

Jane Glover

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFBMTTMBJMBTA
Date   Source Headline
31st Jul 20139:28 amRNSTotal Voting Rights
23rd Jul 20137:00 amRNSCompletion of Share Subscription
18th Jul 20137:00 amRNSBrazil Commercial Agreement
14th Jun 20139:00 amRNSBrazil Soya Field Trial Results
3rd Jun 20137:00 amRNSRepayment of Development Loan & Trading Update
17th May 20132:28 pmRNSHolding(s) in Company
22nd Apr 201311:07 amRNSHolding(s) in Company
22nd Apr 20137:00 amRNSInterim Results
7th Mar 20135:16 pmRNSHolding(s) in Company
25th Feb 201311:42 amRNSAccounting Reference Date Change - Replacement
25th Feb 20137:00 amRNSAccounting Reference Date Change
7th Feb 20139:26 amRNSTotal Voting Rights
7th Jan 20137:00 amRNSResult of Open Offer
4th Jan 20137:00 amRNSDirector/PDMR Shareholding
31st Dec 20127:00 amRNSTotal Voting Rights
24th Dec 20127:00 amRNSDirectorate Change
19th Dec 20127:00 amRNSHalf Yearly Report
18th Dec 20128:15 amRNSHolding(s) in Company
7th Dec 20127:00 amRNSCompletion of Placing & announcement of Open Offer
18th Oct 20122:13 pmRNSBrazil Business Launch
17th Sep 20129:29 amRNSHolding(s) in Company
14th Sep 20129:40 amRNSResult of AGM
10th Sep 201210:18 amRNSDirector's Dealing
5th Sep 201211:08 amRNSHolding(s) in Company
3rd Sep 20121:01 pmRNSChange of Registered Office
17th Aug 201211:09 amRNSNotice of AGM
16th Jul 20127:00 amRNSFinal Results
3rd Jul 201210:00 amRNSResearch Cooperation and Relocation of Head Office
28th Jun 20125:26 pmRNSGrant and Cancellation of Share Options
28th Jun 20125:23 pmRNSFurther Details on Chief Executive Officer
5th Apr 201210:38 amRNSUS EPA BugOil Registration and Trading Update
8th Mar 20123:12 pmRNSExercise of Options
22nd Feb 20128:09 amRNSUS EPA Proposed BugOil Registration Decision
20th Feb 20127:01 amRNSDirectorate Change
20th Feb 20127:00 amRNSAmendment of License & Development Loan Agreements
13th Feb 201211:26 amRNSHolding(s) in Company
1st Feb 20127:35 amRNSPress Speculation
15th Dec 20117:00 amRNSHalf Yearly Report
7th Oct 20117:49 amRNSChange of Adviser
6th Oct 20112:45 pmRNSIssue of Equity
26th Aug 20111:30 pmRNSGrant of share options
26th Aug 201110:40 amRNSResult of AGM
16th Aug 20112:40 pmRNSHolding(s) in Company
16th Aug 20118:15 amRNSDirector/PDMR Shareholding
9th Aug 20117:00 amRNSAppointment of new CEO
4th Aug 20113:30 pmRNSNotice of AGM
4th Jul 201111:30 amRNSPreliminary Results - replacement
4th Jul 20117:00 amRNSHalf Yearly Report
8th Jun 20117:00 amRNSCanadian Distribution Agreement
2nd Jun 20111:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.